Litcius/Paper detail

The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson’s disease

Jiang‐Fan Chen, Rodrigo A. Cunha

2020Purinergic Signalling229 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNeuroprotectionParkinson's diseasePharmacologyAdenosine A2A receptorAdenosine receptor antagonistAntagonistAdenosineDiseaseAdenosine receptorInternal medicineReceptorAgonistAdenosine and Purinergic SignalingParkinson's Disease Mechanisms and TreatmentsConducting polymers and applications
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson’s disease | Litcius